Evidence map›Paper›PMID 32777172›Full record

ReviewCancer medicine2020

Quality and capacity indicators for hospitalized pediatric oncology patients with critical illness: A modified delphi consensus.

Anita V Arias, Marcela Garza, Srinivas Murthy, Adolfo Cardenas, Franco Diaz, Erika Montalvo, Katie R Nielsen, Teresa Kortz, Rana Sharara-Chami, Paola Friedrich and 2 more

Abstract readConsensus StatementReview
In one paragraph

Review in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Establishing nursing-sensitive quality indicators for pediatric oncology: An international mixed methods Delphi study.Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anita V AriasDivision of Pediatric Critical Care, University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0001-7568-5284
Marcela GarzaDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Srinivas MurthyDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Adolfo CardenasHospital Infantil Teletón de Oncología (HITO), Querétaro, México.
Franco DiazFacultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
Erika MontalvoPediatric Critical Care Unit, SOLCA Quito, Quito, Ecuador.
Katie R NielsenDivision of Pediatric Critical Care, University of Washington, Seattle, WA, USA.
Teresa KortzDivision of Pediatric Critical Care, University of California San Francisco, San Francisco, CA, USA.
Rana Sharara-ChamiDepartment of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Paola FriedrichDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jennifer McArthurDivision of Pediatric Critical Care, St. Jude Children's Research Hospital, Memphis, TN, USA.
Asya AgulnikDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-8932-8181

Funding

Fever Etiology and Prognostic Point-of-Care Biomarkers in African Children with Severe Febrile IllnessK23AI144029 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTZ, TERESA · 2020 to 2024
$984k
NIAID NIH HHS K23 AI144029
6 · The paper itself

Abstract

backgroundHospitalized pediatric hematology-oncology (PHO) patients are at high risk for critical illness, especially in resource-limited settings. Unfortunately, there are no established quality indicators to guide institutional improvement for these patients. The objective of this study was to identify quality indicators to include in PROACTIVE (PediatRic Oncology cApaCity assessment Tool for IntensiVe carE), an assessment tool to evaluate the capacity and quality of pediatric critical care services offered to PHO patients.

methodsA comprehensive literature review identified relevant indicators in the areas of structure, performance, and outcomes. An international focus group sorted potential indicators using the framework of domains and subdomains. A modified, three-round Delphi was conducted among 36 international experts with diverse experience in PHO and critical care in high-resource and resource-limited settings. Quality indicators were ranked on relevance and actionability via electronically distributed surveys.

resultsPROACTIVE contains 119 indicators among eight domains and 22 subdomains, with high-median importance (≥7) in both relevance and actionability, and ≥80% evaluator agreement. The top five indicators were: (a) A designated PICU area; (b) Availability of a pediatric intensivist; (c) A PHO physician as part of the primary team caring for critically ill PHO patients; (d) Trained nursing staff in pediatric critical care; and (e) Timely PICU transfer of hospitalized PHO patients requiring escalation of care.

conclusionsPROACTIVE is a consensus-derived tool to assess the capacity and quality of pediatric onco-critical care in resource-limited settings. Future endeavors include validation of PROACTIVE by correlating the proposed indicators to clinical outcomes and its implementation to identify service delivery gaps amenable to improvement.

Indexed as

Critical CareCritical IllnessHospitalizationNeoplasmsPediatricsQuality ImprovementQuality Indicators, Health CareAdultClinical CompetenceCritical Care NursingDelphi TechniqueFemaleHematopoietic Stem Cell TransplantationHumansIntensive Care Units, PediatricMaleclinical cancer researchpediatric cancertranslational research

Identifiers

PMID32777172
PMCPMC7541142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.